Illumina Ethics Advisory Board

Ensuring ethical and just business operations

Illumina is committed to building our company with integrity and ethical business behavior.

The Ethics Advisory Board (EAB) ensures that Illumina acts ethically and justly in its business operations. The EAB meets quarterly to advise and provide recommendations regarding ethical issues involving existing, emerging, and prospective products, services, and processes both from a research and clinical perspective. This includes providing strategic advice to Illumina regarding emerging ethical issues, policies, and regulations relevant to the genomics industry.

Clement Adebamowo, BM, ChB, ScD, 

Leslie Biesecker, MD

Glenn Cohen, JD

Freda Lewis-Hall, MD, DFAPA, MFPM

Nita Farahany, JD, PhD

Charmaine Royal, MS, PhD

Illumina ethics resources

Integrity Principles

Learn how we approach all aspects of our business from a safe, ethical, and responsible standpoint.